Announcements Trials

Browse Landscape

Status

Enrolling by invitation 1

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Prostatic Neoplasms 21 Carcinoma, Non-Small-Cell Lung 21 Breast Neoplasms 20 Neoplasms 19 Stomach Neoplasms 15 Colorectal Neoplasms 15 Lung Neoplasms 13 Endometrial Neoplasms 13 Pancreatic Neoplasms 11 Leukemia, Myeloid, Acute 10 Colonic Neoplasms 9 Carcinoma, Hepatocellular 9 Oropharyngeal Neoplasms 6 Neoplasm Metastasis 6 Multiple Myeloma 6 Melanoma 6 Lymphoma, Large B-Cell, Diffuse 6 Esophageal Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Sarcoma 5 Rectal Neoplasms 5 Mouth Neoplasms 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Head and Neck Neoplasms 5 Uterine Cervical Neoplasms 4 Recurrence 4 Precursor Cell Lymphoblastic Leukemia-Lymphoma 4 Lymphoma, Mantle-Cell 4 Leukemia, Myelomonocytic, Acute 4 Leukemia, Monocytic, Acute 4

Interventions

Metformin 7 Testosterone 2 Pioglitazone 2 Magnetic Resonance Spectroscopy 2 Inositol 2 Exercise 2 Ethinyl Estradiol 2 Blood Pressure 2 semaglutide 1 maltodextrin 1 drospirenone and ethinyl estradiol combination 1 drospirenone 1 bupropion hydrochloride, naltrexone hydrochoride drug combination 1 Walking 1 Vascular Stiffness 1 Ultrasonography 1 Triptorelin Pamoate 1 Topiramate 1 Tirzepatide 1 Sugars 1 Spironolactone 1 Qsymia 1 Pyruvic Acid 1 Pulse Wave Analysis 1 Preoperative Exercise 1 Phlebotomy 1 Phentermine 1 Pancreaticoduodenectomy 1 Orchiectomy 1 Observation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Metabolic Syndrome × Observation × Clear all

NCT07094776 2025-08-06

PCOSMG53

Gaziosmanpasa Research and Education Hospital

Enrolling by invitation

Insulin Resistance, Polycystic Ovary Syndrome, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡